Inactive Instrument

Eurofarma Laboratórios S.A.

Equities

EUFA3

BREUFAACNOR4

Eurofarma Laboratórios S.A. acquired factory in Argentina of Sanofi.

September 17, 2015 at 12:00 am

Eurofarma Laboratórios S.A. acquired factory in Argentina of Sanofi (ENXTPA:SAN) on September 17, 2015.

Eurofarma Laboratórios S.A. completed the acquisition of factory in Argentina of Sanofi (ENXTPA:SAN) on September 17, 2015.

Latest news about Eurofarma Laboratórios S.A.

Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	03-26	CI
Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-26	CI
Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Eurofarma Laboratórios S.A. acquired Genfar S.A. from Sanofi.	23-09-28	CI
Abcuro, Inc. announced that it has received $155 million in funding from a group of investors	23-08-16	CI
Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Abcuro, Inc. announced that it expects to receive $199.522752 million in funding from Redmile Group, LLC, and other investors	23-08-10	CI
Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-26	CI
Eurofarma Laboratórios S.A. agreed to acquire Genfar S.A. from Sanofi for approximately ?300 million.	23-03-07	CI
Eurofarma Laboratórios S.A. acquired Laboratório Canonne for BRL 725 million.	22-12-14	CI
Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-14	CI
Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-29	CI
Pfizer Inc. and BioNTech SE Announce Collaboration with Eurofarma Laboratórios SA to Manufacture COVID-19 Vaccine Doses for Latin America	21-08-26	CI
Eurofarma Laboratórios S.A. cancelled the acquisition of a portfolio of 12 products in Latin America from Hypera S.A..	21-03-16	CI
Eurofarma Laboratórios S.A. entered into agreement to acquire A portfolio of 12 products in Latin America from Hypera S.A. for approximately $160 million.	20-03-16	CI
Biotoscana Confirms Divestiture Negotiations	19-10-09	CI
Melinta Therapeutics Provides for Distribution of Delafloxacin to 19 Countries Through Extended Agreement with Eurofarma Laboratórios	17-09-26	CI
Eurofarma Laboratórios S.A. acquired factory in Argentina of Sanofi.	15-09-17	CI
Melinta Therapeutics, Inc. Partners with Eurofarma Laboratorios S.A	15-01-11	CI
Melinta Therapeutics, Inc. announced that it has received $15 million in funding from Eurofarma Laboratórios S.A.	15-01-07	CI
Eurofarma Laboratorios Ltda. acquired Laboratorios Laprin, S.A.	13-07-04	CI

Chart Eurofarma Laboratórios S.A.

Duration

Period

More charts

Company Profile

Sector

More about the company